CBD

CBD

The Benefits of CBD Oil

Did you know that CBD oil is both legal and already available to buy in the UK?

It comes in all shapes and sizes and contains many of the medicinal benefits of medical cannabis – minus one thing – the THC.

The absence of THC (in anything but minuscule doses) means that CBD oil does not get you high, meaning the oil can be sold as a dietary supplement legally in the UK. Yet this has received next to no media coverage.

What Role Does CBD Play in Medicinal Cannabis and Which Strains Contain the most CBD?

 

In the world of cannabis genetics, a huge variety of big-name strains have placed a lot of emphasis on the THC-producing potential locked within their seeds over the years: more recently, however, with the increasing popularity of medical marijuana, there has been a lot of publicity surrounding the positive effects of one of the lesser known constituents of the herb: Cannabidiol (CBD).

My strains got more CBD than yours

Since the scientific discovery of the cannabis plants main cannabinoid and
psychoactive compound, Delta 9-Tetrahydrocannabinol, we still know only about a
handful – 60ish – named cannabinoids,  and there are potentially hundreds more contained within the cannabis plant.

Responsible cannabis consumers want not only to know the percentages of the
cannabinoids that are present in their pot now, but other than knowing that the
more THC there is the higher you get, consumers now want to know what effect CBD,
CBN, CBG and THCV have on your body, and how that interacts with the THC and
subsequently your high.

Of course it isn’t just the casual consumer that wants to know what’s in their buds… the medicinal value of cannabis is pioneering the efforts in the scientific
setting. Patients with MS, Crohns, Fibromyalgia and Cystic Fibrosis have turned to
cannabis use in place of their “tradtional” pharmaceuticals that, for them and many
others like them, do not work.

One cannabinoid that has been stealing THC’s longstanding limelight is CBD or
Cannabidiol. There are several very good reasons for this shift of attention.

While THC is responsible, or to blame, for the “high” when you smoke, vaporize or eat
cannabis it is also to thank for the huge pain relieving quality of the herb and as
the Huffington Post brought to my attention this month (Aug 24th 2011) “The number of
deaths from prescription painkillers – opioids, such as OxyContin, Vicodin and
hydrocodone – in the United States has now surpassed that of skin cancer, alcoholic
liver disease and HIV, according to a new study published online in the British
Medical Journal.”

THC is also said to be the cause of paranoia and strains that are high in this
psychoactive compound are labelled “Skunk Cannabis” by the media and government in
the UK and attribute it to the modern epidemic of Cannabis Psychosis. The formula to
work out if you have this terrible syndrome is quite complex but as far as I can work
out it starts off by – the younger you were when you first smoked cannabis to the
time you tried it next increases your risk of psychosis if you were younger your
first time and you experienced a longer gap between your first and second experiences
again increased by your number of joint years which is how many joints you smoke a
day everyday.

But that’s according to the government and I like to get my information from science.

CBD has changed the story somewhat, both on the scientists’ and governments’ sides of
the fence. The property that CBD has had shouted about the most is by no means the
most important but it goes to show you about the intentions of the media *ahem*
sensationalism *ahem*, but that’s no suprise seeing as they like to throw the anti on
THC so readily.

CBD is an anti-psychotic. This means that it is a great treatment for psychosis,
schizophrenia and paranoia… three syndromes that THC is laid blame for. The evidence
that has been put forward now has become so compelling that the tabloid media have
had to make a shift on what they call “skunk cannabis” from strains high in THC to
strains low in CBD. Traditionally they would report on Skunk Cannabis being 18%
potent but with the new rules, as long as the CBD is virtually nonexistent, 6% THC
seems to do the job for them.

What scientists have observed with CBD in the lab is a counteractive effect to THC.
This has somewhat been echoed by users of cannabis saying that higher CBD strains
tend to have less of a rush or euphoria to them. It has also been reported that CBD
“reduces growth of aggressive human breast cancer cells in vitro and reduces their
invasiveness.”

Other medical uses for CBD are as an anti-inflammatory, anti-convulsive, anti-emitic
(nausea), anti-spasmodic and has most noticeably been used in the world’s first modern
cannabis “based” medicine in the form of Sativex patented by GW Pharmaceuticals in
every continent now other than the Americas (Sativex is currently awaiting stage 3
trials for cancer pain in the US and was first available on prescription in Canada, 2005).

So, this science has managed to overpower the UK government and force them to change
their official stance of cannabis from “not a medicine” to “not a medicine in herbal
form” because of course GW Pharma can grow around a dozen ware-houses of it, and
profit from it at that, WITH explicit permission from Her Majesty’s Government.

Sativex is actually developed from a strain known as Skunk#1 so the very notion
that Skunk Cannabis could be harmful when it is actually the main ingredient to an
accepted form of medical cannabis and an accepted form of cannabis at that. A
whole plant extract via a Super Critical CO2 high pressure machine which produces a
very dark and sticky hash oil, mixed with ethanol and peppermint oil, then packaged
in spray bottles that with each press dispense 2.3mg of THC and 2mg of CBD. The
effect on the user is pain relief and reduction in spasms and tremors as it is most
commonly prescribed to MS patients although chronic pain is an accepted condition in
areas that have not decided to ban it due to the cost.

The list of positive side-effects is so desirable, CBD rich strains have become the
choice of many medicinal users according to a few dispensaries like SPARC and
Harborside Health Center in the Bay Area who make strains available such as Jamaican
Lion (8%), Harlequin (12%) and Trident (14%) that all have higher CBD levels than
THC.

Project CBD

By Tracey Walters for Issue 12 of ISMOKE Magazine

Just about a year ago, when I began my career in drug policy activism, I came across an opportunity to work with Project CBD.

Conceived by Martin Lee and Fred Gardener; Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD).

Cannabidiol is a non-psychoactive cannabinoid compound that has been found to have enormous therapeutic potential to aid various conditions including: cancer, multiple sclerosis, PTSD, sleep disorders, anxiety, diabetes, epilepsy, alcoholism, neurological disorders and more. CBD has a synergistic relationship with THC. Cannabidiol enhances THC’s painkilling impact, while muting THC’s psychoactivity. Users may be able to use CBD-rich strains without feeling “stoned”. Not everyone enjoys the THC high. Strains that have a higher CBD ratio may be an appealing option for those who want the medicinal benefits of cannabis without the daze.

In the past, some strains naturally had a high CBD content, but the market and breeders favored higher THC ratios. Now CBD is making a reintroduction into the grassroots supply. Project CBD is focused on bringing the latest news related to cannabidiol and other components of the cannabis plant to our readers.

Project CBD believes that the reintroduction of CBD-rich cannabis into the grassroots supply warrants special focus. We work to make sure that developments in cannabinoid science are reported, so that doctors and patients can be kept updated on the most recent research available. We also publicize data regarding patterns of CBD efficacy and report on greater aspects of the cannabis movement.
While CBD is a non-psychoactive component of cannabis, we defend whole plant cannabis therapeutics. Project CBD refutes the slander that medicinal marijuana is “a front for stoners.”

While working with Project CBD, I have been able to meet and befriend medical cannabis users who get enormous relief of their symptoms from using CBD-rich strains. Clark French, a cannabis activist from the UK who works with CLEAR, uses cannabis to manage his multiple sclerosis. He believes that CBD-rich strains have given him the most pain relief. One afternoon he showed me just how much relief CBD gives him. He asked me to feel a muscle spasm in his upper back. Lightly pressing on the spot, I could clearly feel the tension in his back. Then he medicated with Harlequin (a CBD-rich strain) and in less than fifteen minutes he reported that the tension was gone. I confirmed this when I pressed the same spot afterwards.

In the beginning of my work with Project CBD, I knew relatively little about cannabidiol. Now I am better able to understand CBD and even able to feel the relief it gives others and myself. This has given me enormous hope for the future of conscious medicine. When I first focused my life goal to on changing society’s perspective on natural medicines, I was terrified. Everyday I work with Project CBD, my path becomes clearer and I am able to meet others who share my beliefs and experiences. Project CBD has become a huge part of my life and I want to share it with as many people as I possibly can. I encourage you to do the same, because you never know who CBD can help.

There are many people in this world who are suffering from conditions which cannabis, including CBD-rich medicine, can alleviate thereby giving them a better quality of life. I believe it is important to let them know that such a thing exists.

I have shared my experience, and we encourage others to share their experiences – positive and negative – with CBD-rich medicine. To find out more about our organization, become involved, or to take the CBD patient survey, visit our website at projectcbd.org. To keep up to date with the latest news about Project CBD, you may cruise our website, “like” us on Facebook, and follow us on Twitter. Questions and comments are welcomed: [email protected]